← Back to Search

Sodium Fluorescein for Neurosurgical Tumors

N/A
Waitlist Available
Led By Todd Hankinson, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-op assessment to outpatient follow up, up to 6 weeks
Awards & highlights

Study Summary

This trial found that using sodium fluorescein can help during the resection of pediatric neurosurgical tumors.

Eligible Conditions
  • Pediatric Neurosurgical Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-op assessment to outpatient follow up, up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-op assessment to outpatient follow up, up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Tumor Resected: Intracranial Lesions
Percent of Tumor Resected: Spinal Lesions
Secondary outcome measures
Positive Predictive Value
Sensitivity of Tumor Resection
Specificity of Tumor Resection
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sodium-Fluorescein ResectionExperimental Treatment2 Interventions
This study will employ the use of sodium fluorescein and an FDA approved operative microscope equipped with excitation and barrier filters for monitoring with sufficient fluorescent enhancement and contrast.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fluorescein
FDA approved

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,726 Previous Clinical Trials
2,141,674 Total Patients Enrolled
Todd Hankinson, MDPrincipal InvestigatorChildren's Hospital Colorado
1 Previous Clinical Trials
250 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a way for me to participate in this experiment?

"Eligibility criteria for this study include a minimum age of 31 days and no more than 21 years old, with cancer as the primary condition. The trial plans to accept 120 participants in total."

Answered by AI

Has the research community conducted any previous investigations regarding Sodium Fluorescein?

"At this time, there are 7 Sodium Fluorescein trials that have yet to be completed and one of these is in the third Phase. While Ann Arbor, Michigan hosts most of the experiments involving Sodium Fluorescein, a total of 222 sites across the world are conducting such studies."

Answered by AI

What goals is this experiment hoping to accomplish?

"During the pre-operative assessment to outpatient follow up period, extending for 6 weeks, researchers will primarily evaluate the percentage of intracranial tumors resected. Secondary objectives include assessing positive predictive value with contingency tables and data from tumour extraction; gauging specificity by correlating fluorescein staining to histopathological diagnosis; and estimating sensitivity through similar correlation techniques."

Answered by AI

To what extent is this research project being populated?

"Affirmative, the information found on clinicaltrials.gov affirms that this medical research is being conducted presently. The trial was initiated in August 2021 and lastly updated September 2022; they are searching for 120 individuals from a single site."

Answered by AI

What medical purpose is Sodium Fluorescein typically employed for?

"Sodium Fluorescein is frequently used when treating patients with peritoneal dialysis therapy. Additionally, it may be beneficial for those suffering from lymphocyte count measurement issues, as well as pneumocystis jirovecii pneumonia and other forms of the genus pneumocystis."

Answered by AI

Does the study protocol accept individuals aged seventy or above?

"This clinical trial is accessible to individuals between 31 days and 21 years of age. Notably, there are 301 trials for paediatric patients and 2209 studies targeting elderly adults."

Answered by AI

Are there currently any openings for enrolment in this investigation?

"According to the data accessible on clinicaltrials.gov, this experiment is currently seeking eligible individuals; it was initially posted on August 11th 2021 and revised recently on September 16 2022."

Answered by AI
~1 spots leftby Mar 2025